Preimplantation genetic testing for aneuploidy (PGT-A) remains one of the most
controversial topics in reproductive medicine. With more than 40% of in vitro fertilization …

Aneuploidy is common among preimplantation human embryos used in assisted
reproductive technology. Because abnormal chromosome number can negatively affect …

Abstract Preimplantation Genetic Testing (PGT) aims to reduce the chance of an affected
pregnancy or improve success in an assisted reproduction cycle. Since the first established …

Research question Non-invasive preimplantation genetic testing for aneuploidies (niPGT-A)
avoids the possible detrimental impact of invasive PGT-A on embryo development and …

Advancements in assisted reproduction (AR) methodologies have allowed significant
improvements in live birth rates of women who otherwise would not be able to conceive …

Background The objective of this study was to explore the clinical application of noninvasive
chromosomal screening (NICS) for elective single-blastocyst transfer (eSBT) in frozen …

Purpose This preclinical study aimed to evaluate whether using transferred mosaic embryos
(primarily selected by embryonic morphology assessment (EMA) and compared by the …

Background Previous studies have shown that optimal blood pressure (BP) control is
necessary to outcomes in patients with acute myocardial infarction (AMI). Acute left …

Detection of chromosomal aneuploidies and monogenic disorders in preimplantation
embryos is essential for selecting the best embryo for transfer during in vitro fertilization to …

Background/Aim: Preimplantation genetic testing (PGT) for chromosomal screening, based
on embryo biopsy, has significant limitations. Cell-free DNA (cf-DNA) has been detected in …